New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis
Source: Pixabay.com

New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis

According to a story from bioportfolio.com, two companies, Ionis Pharmaceuticals, Inc., and its affiliate Akcea Pharmaceuticals, recently announced that its product inotersen (to be marketed as TEGSEDI) has gained approval…

Continue Reading New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis
An Experimental Drug For Treating Duchenne Muscular Dystrophy Will be Studied in a Phase 3 Trial, Catabasis Says
stevepb / Pixabay

An Experimental Drug For Treating Duchenne Muscular Dystrophy Will be Studied in a Phase 3 Trial, Catabasis Says

Catabasis Pharmaceuticals Inc. has announced plans for a Phase 3 clinical trial called Polaris DMD. It will investigate the experimental drug edasalonexent for the treatment of patients with Duchenne muscular…

Continue Reading An Experimental Drug For Treating Duchenne Muscular Dystrophy Will be Studied in a Phase 3 Trial, Catabasis Says
How Rare is Eosinophilic Esophagitis Anyway? A Family’s Story Brings Awareness
White77 / Pixabay

How Rare is Eosinophilic Esophagitis Anyway? A Family’s Story Brings Awareness

According to a story from the Washington Times-Reporter, Michelle Marcinak's three sons-- John Henry, Leo, and Rafe-- were all diagnosed with the rare gastric condition eosinophilic esophagitis. Early symptoms of…

Continue Reading How Rare is Eosinophilic Esophagitis Anyway? A Family’s Story Brings Awareness
Investigational Drug for Facioscapulohumeral Muscular Dystrophy Gets Orphan Drug Designation
simple_tunchi0 / Pixabay

Investigational Drug for Facioscapulohumeral Muscular Dystrophy Gets Orphan Drug Designation

According to a story from BioSpace, the biopharmaceutical company Acceleron Pharma, which develops TGF-beta based treatments for rare and serious illnesses, recently announced that the U.S. Food and Drug Administration…

Continue Reading Investigational Drug for Facioscapulohumeral Muscular Dystrophy Gets Orphan Drug Designation
Kids With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Experience Complications and Get Inconsistent Treatment, Study Says
RachelBostwick / Pixabay

Kids With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Experience Complications and Get Inconsistent Treatment, Study Says

According to a story from ScienceDaily, a recent analysis has been conducted in order to investigate patient outcomes for children with the rare skin condition Stevens-Johnson syndrome, as well its…

Continue Reading Kids With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Experience Complications and Get Inconsistent Treatment, Study Says

Online Community Helped Free a Family Affected by Coffin-Siris Syndrome From Isolation

According to a story from the Globe and Mail, Michelle Quinlan was overwhelmed when her child Avery was diagnosed with Coffin-Siris syndrome, a rare genetic disease that can cause intellectual…

Continue Reading Online Community Helped Free a Family Affected by Coffin-Siris Syndrome From Isolation

Positive Genetic Test Results for Rare Disease Risk are not Necessarily a Cause for Alarm

According to a story from Global News, direct-to-consumer genetic tests are becoming increasingly popular. These tests can be used to learn new info about your ancient ancestors, closer relatives, and,…

Continue Reading Positive Genetic Test Results for Rare Disease Risk are not Necessarily a Cause for Alarm
Five Benefits of the New Pig Models of Huntington’s Disease, According to Scientists
Source: Pixabay

Five Benefits of the New Pig Models of Huntington’s Disease, According to Scientists

New pig models of Huntington’s disease have been developed, and they are expected to have several benefits compared to existing rodent models of the condition. Read the source article here…

Continue Reading Five Benefits of the New Pig Models of Huntington’s Disease, According to Scientists
Encouraging Results Have Been Announced From a Trial of an Investigational Treatment For BPDCN
kkolosov / Pixabay

Encouraging Results Have Been Announced From a Trial of an Investigational Treatment For BPDCN

Results from research into an experimental therapy called SL-401 for the treatment of patients with blastic plasmacytoid dendritic cell neoplasm have been shared at the Congress of the European Haematology…

Continue Reading Encouraging Results Have Been Announced From a Trial of an Investigational Treatment For BPDCN
Kalytera Therapeutics Will Meet with the FDA to Discuss Cannabidiol as a Possible Treatment For Acute GVHD
889520 / Pixabay

Kalytera Therapeutics Will Meet with the FDA to Discuss Cannabidiol as a Possible Treatment For Acute GVHD

Kalytera Therapeutics, Inc. has announced that a meeting with the Centre for Drug Evaluation and Research of the US FDA is planned for Tuesday, 31st July this year. The purpose of…

Continue Reading Kalytera Therapeutics Will Meet with the FDA to Discuss Cannabidiol as a Possible Treatment For Acute GVHD
Could Virtual Reality Cure Glaucoma?
Source: Pixabay

Could Virtual Reality Cure Glaucoma?

According to a story published by STAT, a daredevil neuroscientist at Stanford University is utilizing the relatively new concept of virtual reality to solve an unsuspecting problem. Not only is…

Continue Reading Could Virtual Reality Cure Glaucoma?

BrainStorm Has Secured a Second Manufacturing Facility for NurOwn, an Experimental Drug for ALS

BrainStorm Cell Therapeutics Inc. has announced that it has secured its second U.S. manufacturing location for NurOwn®, an experimental drug currently under investigation for the treatment of amyotrophic lateral sclerosis…

Continue Reading BrainStorm Has Secured a Second Manufacturing Facility for NurOwn, an Experimental Drug for ALS

A New Treatment for Dupuytren’s Contracture Could Improve Outcomes

According to a story from the Deccan Chronicle, researchers may have discovered a new treatment for Dupuytren's contracture that could offer substantial benefits over currently available treatment options. The scientists…

Continue Reading A New Treatment for Dupuytren’s Contracture Could Improve Outcomes